neximmune.com - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi NEXI
NexImmune, Inc. (NEXI) is developing T-cell activation methods amidst intense patent battles and high R&D costs. The annual EBITDA figure allows for real-time tracking of cash flow, while indicates the level of this metric. The project relies on the innovative AIM platform in US laboratories, while ensuring the seamless delivery of critical reagents.
NexImmune - rincian analitis lan metrik utama (NEXI)
- nilai pasar lan prakiraan target analis:
- rincian nilai pasar emiten:
- informasi kapitalisasi buku:
- rincian struktur utang lan likuiditas bisnis:
Rasio Total Utang marang Ekuitas NexImmune, Inc.|NEXI - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal NexImmune Inc|NEXI - Utang perusahaan|Rasio utang marang nilai buku NexImmune|NEXI - Utang jangka dawa perusahaan|Utang jangka cendhak NexImmune|Likuiditas kritis neximmune.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
NEXI - Penghasilan resik|Bathi resik mangsa ngarep NexImmune, Inc.|NEXI - Pangali P/E|Pangali mangsa ngarep rega marang bathi neximmune.com|NEXI - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan NexImmune|NEXI - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku NexImmune|NEXI - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan neximmune.com|NEXI - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep NexImmune, Inc.
Analisis kabeh metrik perusahaan:NexImmune Corporation - NEXI
NexImmune, Inc. (NEXI) occupies a promising niche within the underserved T-cell cancer immunotherapy segment, where high clinical demand drives scaling potential. By analyzing the EBITDA chart, an investor assesses the net cash flow from core operations without the impact of debt service; steady growth in this metric confirms the business's fundamental stability, whereas stagnation signals risks of asset impairment.
Pesaing NexImmune, Inc. (NEXI)
NantKwest (IBRX) - Bathi sadurunge bunga, pajak, lan amortisasi|IMCR: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi JANX (januxrx.com)|RCUS: Bathi operasional EBITDA|ZYME - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Tango Pharma|Bathi operasional sadurunge ngurangi amortisasi Iovance Corp (IOVA)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Immatics N.V. (IMTX)|Bathi operasional sadurunge ngurangi amortisasi xencor.com XNCR|Compass Therapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA Replimune Group Inc REPL|LYEL - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|IPHA (Innate Pharma S.A) - Bathi operasional sadurunge amortisasi|pyxisoncology.com (PYXS) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Compugen (CGEN)|Bathi operasional sadurunge ngurangi amortisasi IOBT|STRO - Bathi operasional sadurunge potongan amortisasi|Bathi operasional sadurunge ngurangi amortisasi INKT (MiNK)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi HOWL|Bathi operasional EBITDA IMMX (Immix Biopharma)|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi ALXO|Cue Biopharma, Inc. - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi PDS Biotechnology|sonnetbio.com (SONN) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|MAIA Bio - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|LIMN (Liminatus Pharma) - Bathi operasional EBITDA|Bathi operasional EBITDA Lava Tx|Bathi sadurunge mbayar bunga, pajak, lan amortisasi NextCure (NXTC)|LPTX: Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Intensity Therapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Sensei Biotherapeutics Inc (SNSE) - Bathi sadurunge bunga, pajak, lan amortisasi|TOVX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|GRTS (Gritstone bio, Inc.) - Bathi operasional sadurunge amortisasi|KA: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Turnstone Biologics Corp. (TSBX)|Bathi operasional sadurunge ngurangi amortisasi VCNX|Bathi operasional sadurunge amortisasi HARP (Harpoon Therapeutics Corp)
